Phase 2 Lung Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Adults aged 18 or older who are seen at TOHCC and have been diagnosed with advanced lung cancer (specifically stage IIIB or stage IV non-small cell lung cancer)
- People who are scheduled to receive their first course of platinum-based chemotherapy, with or without immunotherapy at the same time
Who may not be able to join:
- People whose physical functioning and ability to care for themselves is significantly limited (based on a standard medical scoring system — confirm with trial site)
- People who have received intravenous vitamin C (IVC) within the 6 months before joining the trial
- People who have a condition called G6PD deficiency, which affects how the body processes certain substances
- People whose kidneys are not filtering blood well enough (a kidney function measurement below a certain level — confirm with trial site)
- People who are currently taking insulin or the blood-thinning medication warfarin
- People with a history of severe kidney problems or a condition called hemochromatosis (a condition involving too much iron in the body)
- People who have received chemotherapy or immunotherapy within the 12 months before joining the trial
- People who are pregnant or planning to become pregnant and carry a gene linked to G6PD deficiency
- People who are currently taking part in another clinical trial or have done so in the past 30 days
- People who, for any other reason, the lead doctor overseeing the trial considers unsuitable to participate
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 613-792-1222
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Change in Quality of Life
Can't join this trial?
Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.